Tag: Valuation

Biotech

Deal Analysis: Research Institute Contemplating Acquisition

Background An established, biomedical research facility was looking to enter into an agreement with a hospital organization which would absorb the research institute in exchange …

Read More
Biotech

Strategic Modeling Alternatives for a Clinical Stage Pharmaceutical Company

Background A pharmaceutical company, in the midst of a Phase III clinical trial, was considering a variety of strategic and financing alternatives as it prepared …

Read More
Crypto & Blockchain

Cryptocurrency and Token Distributions – A Teknos Perspective

Over the past several years, Teknos has valued hundreds of types of cryptocurrencies and tokens (utility, security, stable, etc.) for a variety of purposes.  Over …

Read More
Esports & Gaming

Esports Team Contemplating Management Buyout

Background While growth in Esports has been rapid over recent years, this growth can often result in the need for adjustments to overarching strategic initiatives …

Read More
ASC 820

Your Investments and ASC 820

The financial reporting requirements of ASC 820 can be overwhelming for the finance teams of any venture capital firm.  Fortunately, Teknos Associates provides a customized …

Read More
Biotech

Complexities in Biotechnology

Biotechnology companies face unique challenges when it comes to understanding the value of their assets.  During the early stages of development, an extraordinary level of …

Read More
Commentary

IRC 409A: It’s Not Just About Tax

IRC 409A became part of the tax code on January 1, 2009.  So, what have we learned in recent years*? One of the biggest surprises …

Read More
Commentary

Three Best Practices in Valuation for Companies Planning an IPO

A number of Teknos client companies complete an IPO every year and we thought that it would be worthwhile to share the best practices that …

Read More
Commentary

Three Common Stock Transactions That May Affect Your IRC §409A Valuation

In the past, common stockholders had to wait for a company to complete an IPO or to be acquired in order to sell their shares.  …

Read More